文献速递甲状腺疾病

基于心血管疾病风险界定甲状腺功能的最佳健康范围

Defining Optimal Health Range for Thyroid Function Based on the Risk of Cardiovascular Disease.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

在鹿特丹研究中,9233名参与者(平均年龄65.0岁)随访中位8.8年,共689例心血管疾病死亡。游离甲状腺素(FT4)高于第90百分位与预测10年心血管疾病死亡风险>7.5%相关(P=0.005);年龄≥65岁者FT4低于第30百分位(约14.5 pmol/L或1.10 ng/dL)时绝对风险<10.0%,高于第97百分位(约22 pmol/L或1.70 ng/dL)时≥15.0%。作者提出甲状腺功能最佳健康范围可根据疾病风险界定,并可能受性别和年龄影响。

要点

  • FT4高于第90百分位与预测10年心血管疾病死亡风险>7.5%相关(P=0.005)。
  • 男性FT4高于第97百分位与10.8%的风险相关(P<0.001)。
  • 年龄≥65岁者FT4低于第30百分位(约14.5 pmol/L或1.10 ng/dL)时绝对风险<10.0%。

核心结论

  • 作者描述了按甲状腺功能(TSH和FT4)划分的10年心血管疾病死亡绝对风险,并提出甲状腺功能的最佳健康范围可根据疾病风险界定,且可能受性别和年龄影响。

研究设计与样本

  • 鹿特丹研究纳入9233名参与者(平均年龄65.0岁),从基线随访至死亡日期或随访期结束(2012年),以先发生者为准,中位随访8.8年,共689例心血管疾病死亡。

主要发现

  • 总体FT4高于第90百分位与预测10年心血管疾病死亡风险>7.5%相关(P=0.005)。
  • 男性FT4高于第97百分位与10.8%的风险相关(P<0.001)。
  • 年龄≥65岁参与者中,FT4低于第30百分位(约14.5 pmol/L或1.10 ng/dL)时绝对风险估计<10.0%,FT4高于第97百分位(约22 pmol/L或1.70 ng/dL)时≥15.0%。

关键数值与推荐

  • FT4高于第90百分位对应的预测10年心血管疾病死亡风险>7.5%(P=0.005)。
  • 男性FT4高于第97百分位对应的风险为10.8%(P<0.001)。
  • 年龄≥65岁者FT4低于第30百分位(约14.5 pmol/L或1.10 ng/dL)时绝对风险<10.0%。
  • 年龄≥65岁者FT4高于第97百分位(约22 pmol/L或1.70 ng/dL)时绝对风险≥15.0%。

临床怎么用

  • 作者提出甲状腺功能的最佳健康范围可根据疾病风险界定,并可能受性别和年龄影响。

局限性

  • 作者指出这些结果需要用足够样本量和代表性人群进行重复验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Reference ranges of thyroid-stimulating hormone (TSH) and free thyroxine (FT4) are defined by their distribution in apparently healthy populations (2.5th and 97.5th percentiles), irrespective of disease risk, and are used as cutoffs for defining and clinically managing thyroid dysfunction. OBJECTIVE: To provide proof of concept in defining optimal health ranges of thyroid function based on cardiovascular disease (CVD) mortality risk. DESIGN AND PARTICIPANTS: In all, 9233 participants from the Rotterdam Study (mean age, 65.0 years) were followed up (median, 8.8 years) from baseline to date of death or end of follow-up period (2012), whichever came first (689 cases of CVD mortality). MAIN OUTCOMES: We calculated 10-year absolute risks of CVD mortality (defined according to the SCORE project) using a Fine and Gray competing risk model per percentiles of TSH and FT4, modeled nonlinearly and with sex and age adjustments. RESULTS: Overall, FT4 level >90th percentile was associated with a predicted 10-year CVD mortality risk >7.5% (P = 0.005). In men, FT4 level >97th percentile was associated with a risk of 10.8% (P < 0.001). In participants aged ≥65 years, absolute risk estimates were <10.0% below the 30th percentile (∼14.5 pmol/L or 1.10 ng/dL) and ≥15.0% above the 97th percentile of FT4 (∼22 pmol/L or 1.70 ng/dL). CONCLUSIONS: We describe absolute 10-year CVD mortality risks according to thyroid function (TSH and FT4) and suggest that optimal health ranges for thyroid function can be defined according to disease risk and are possibly sex and age dependent. These results need to be replicated with sufficient samples and representative populations.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Chaker L, Korevaar TIM, Rizopoulos D, et al. Defining Optimal Health Range for Thyroid Function Based on the Risk of Cardiovascular Disease. J Clin Endocrinol Metab. 2017. PMID: 28520952. doi:10.1210/jc.2017-00410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。